Quantification of epicardial adipose tissue by computed tomographic scanning as a prognostic criterion of atrial fibrillation recurrence after catheter ablation
https://doi.org/10.18087/cardio.2023.8.n2168
Abstract
Aim This study focused on a systematic review and meta-analysis on the predictive role of quantifying the epicardial adipose tissue (EAT) volume using data of computed tomography (CT) in patients after catheter ablation for atrial fibrillation (AF).
Material and methods We performed a search in PubMed and Google Scholar for studies that examined the predictive value of EAT volume measured by CT for AF recurrence in patients after undergoing pulmonary venous isolation. Risk ratio (RR) values from studies, where similar scoring criteria were available, were pooled for the meta-analysis.
Results Eighteen studies were selected from 901 publications for these systematic review and meta-analysis. In total, 4087 patients were included in this analysis (mean age, 59.0 years; mean follow-up duration, 14.9 mos). Patients with recurrent AF after ablation had higher left atrial EAT volume compared to patients without relapse (weighted mean difference, 5.99 ml; 95% CI: -10.04 to -1.94; p = 0.004). An increase in left atrial EAT volume per ml was significantly associated with the development of AF recurrence after ablation (RR 1.08; 95% CI: 1.01 to 1.16; p=0.03). Patients with recurrent AF after ablation also had higher total EAT values than patients without relapse (difference in weighted values, 11.67 ml; 95% CI: -19.81 to -3.54; p = 0.005). However, no significant association was found between the total EAT volume and the risk of AF relapse (RR 1.00; 95% CI: 1.00 to 1.01; p=0.06).
Conclusions The volume of left atrial EAT measured by CT has a significant predictive value in AF patients after catheter ablation and can be used for stratification of the risk for recurrent AF.
Keywords
About the Authors
E. Z. GolukhovaRussian Federation
MD, Professor, Academician of Russian Academy of Sciences
Moscow, Russia
N. I. Bulaeva
Russian Federation
MD, PhD, Senior Research Associate
Moscow, Russia
S. A. Alexandrova
Russian Federation
MD, PhD, Senior Research Associate
Moscow, Russia
A. A. Saparbaev
Russian Federation
MD, Junior Research Associate
Moscow, Russia
A. A. Abgaryan
Russian Federation
MD, Postgraduate
Moscow, Russia
B. Sh. Berdibekov
Russian Federation
MD, Junior Research Associate
Moscow, Russia
References
1. Ganesan AN, Shipp NJ, Brooks AG, Kuklik P, Lau DH, Lim HS et al. Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis. Journal of the American Heart Association. 2013;2(2):e004549. DOI: 10.1161/JAHA.112.004549
2. Arbelo E, Brugada J, Lundqvist CB, Laroche C, Kautzner J, Pokushalov E et al. Contemporary management of patients undergoing atrial fibrillation ablation: in-hospital and 1-year follow-up findings from the ESC-EHRA atrial fibrillation ablation long-term registry. European Heart Journal. 2017;38(17):1303–16. DOI: 10.1093/eurheartj/ehw564
3. Golukhova E.Z., Gromova O.I., Bulaeva N.I., Arakelyan M.G., Lifanova L.S., Shlyappo M.A. et al. Epicardial Fat and Atrial Fibrillation: the Role of Profibrinogenic Mediators. Kardiologiia. 2018;58(7):59–65. DOI: 10.18087/cardio.2018.7.10145
4. Wong CX, Sullivan T, Sun MT, Mahajan R, Pathak RK, Middeldorp M et al. Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation. JACC: Clinical Electrophysiology. 2015;1(3):139–52. DOI: 10.1016/j.jacep.2015.04.004
5. Thanassoulis G, Massaro JM, O’Donnell CJ, Hoffmann U, Levy D, Ellinor PT et al. Pericardial Fat Is Associated With Prevalent Atrial Fibrillation: The Framingham Heart Study. Circulation: Arrhythmia and Electrophysiology. 2010;3(4):345–50. DOI: 10.1161/CIRCEP.109.912055
6. Bonou M, Mavrogeni S, Kapelios CJ, Markousis-Mavrogenis G, Aggeli C, Cholongitas E et al. Cardiac Adiposity and Arrhythmias: The Role of Imaging. Diagnostics. 2021;11(2):362. DOI: 10.3390/diagnostics11020362
7. Nagashima K, Okumura Y, Watanabe I, Nakai T, Ohkubo K, Kofune T et al. Association Between Epicardial Adipose Tissue Volumes on 3-Dimensional Reconstructed CT Images and Recurrence of Atrial Fibrillation After Catheter Ablation. Circulation Journal. 2011;75(11):2559–65. DOI: 10.1253/circj.CJ-11-0554
8. Nakahara S, Hori Y, Kobayashi S, Sakai Y, Taguchi I, Takayanagi K et al. Epicardial adipose tissue-based defragmentation approach to persistent atrial fibrillation: Its impact on complex fractionated electrograms and ablation outcome. Heart Rhythm. 2014;11(8):1343–51. DOI: 10.1016/j.hrthm.2014.04.040
9. Tsao H-M, Hu W-C, Wu M-H, Tai C-T, Lin Y-J, Chang S-L et al. Quantitative Analysis of Quantity and Distribution of Epicardial Adipose Tissue Surrounding the Left Atrium in Patients With Atrial Fibrillation and Effect of Recurrence After Ablation. The American Journal of Cardiology. 2011;107(10):1498–503. DOI: 10.1016/j.amjcard.2011.01.027
10. Kim T-H, Park J, Park J-K, Uhm J-S, Joung B, Lee M-H et al. Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: An analysis of over 600-patients. International Journal of Cardiology. 2014;176(3):841–6. DOI: 10.1016/j.ijcard.2014.08.008
11. Kocyigit D, Gurses KM, Yalcin MU, Turk G, Evranos B, Yorgun H et al. Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation. Journal of Cardiovascular Computed Tomography. 2015;9(4):295–302. DOI: 10.1016/j.jcct.2015.03.011
12. Masuda M, Mizuno H, Enchi Y, Minamiguchi H, Konishi S, Ohtani T et al. Abundant epicardial adipose tissue surrounding the left atrium predicts early rather than late recurrence of atrial fibrillation after catheter ablation. Journal of Interventional Cardiac Electrophysiology. 2015;44(1):31–7. DOI: 10.1007/s10840-015-0031-3
13. Maeda M, Oba K, Yamaguchi S, Arasaki O, Sata M, Masuzaki H et al. Usefulness of Epicardial Adipose Tissue Volume to Predict Recurrent Atrial Fibrillation After Radiofrequency Catheter Ablation. The American Journal of Cardiology. 2018;122(10):1694–700. DOI: 10.1016/j.amjcard.2018.08.005
14. Sanghai SR, Sardana M, Hansra B, Lessard DM, Dahlberg ST, Aurigemma GP et al. Indexed Left Atrial Adipose Tissue Area Is Associated With Severity of Atrial Fibrillation and Atrial Fibrillation Recurrence Among Patients Undergoing Catheter Ablation. Frontiers in Cardiovascular Medicine. 2018;5:76. DOI: 10.3389/fcvm.2018.00076
15. Kawasaki M, Yamada T, Furukawa Y, Morita T, Tamaki S, Kida H et al. Are cardiac sympathetic nerve activity and epicardial adipose tissue associated with atrial fibrillation recurrence after catheter ablation in patients without heart failure? International Journal of Cardiology. 2020;303:41– 8. DOI: 10.1016/j.ijcard.2019.11.092
16. Tanisawa H, Akutsu Y, Ito H, Nomura K, Sekimoto T, Kaneko K et al. Epicardial Adipose Tissue in the Right Atrium Is Associated with Progression of Atrial Fibrillation and Recurrence after Pulmonary Vein Catheter Ablation in Patients with Atrial Fibrillation. The Showa University Journal of Medical Sciences. 2020;32(1):11–24. DOI: 10.15369/sujms.32.11
17. Romanov A, Minin S, Nikitin N, Ponomarev D, Shabanov V, Losik D et al. The relationship between global cardiac and regional left atrial sympathetic innervation and epicardial fat in patients with atrial fibrillation. Annals of Nuclear Medicine. 2021;35(10):1079–88. DOI: 10.1007/s12149-021-01643-2
18. Hammache N, Pegorer-Sfes H, Benali K, Magnin Poull I, Olivier A, Echivard M et al. Is There an Association between Epicardial Adipose Tissue and Outcomes after Paroxysmal Atrial Fibrillation Catheter Ablation? Journal of Clinical Medicine. 2021;10(14):3037. DOI: 10.3390/jcm10143037
19. El Mahdiui M, Simon J, Smit JM, Kuneman JH, Van Rosendael AR, Steyerberg EW et al. Posterior Left Atrial Adipose Tissue Attenuation Assessed by Computed Tomography and Recurrence of Atrial Fibrillation After Catheter Ablation. Circulation: Arrhythmia and Electrophysiology. 2021;14(4):e009135. DOI: 10.1161/CIRCEP.120.009135
20. Beyer C, Tokarska L, Stühlinger M, Feuchtner G, Hintringer F, Honold S et al. Structural Cardiac Remodeling in Atrial Fibrillation. JACC: Cardiovascular Imaging. 2021;14(11):2199–208. DOI: 10.1016/j.jcmg.2021.04.027
21. Yang M, Cao Q, Xu Z, Ge Y, Li S, Yan F et al. Development and Validation of a Machine Learning-Based Radiomics Model on Cardiac Computed Tomography of Epicardial Adipose Tissue in Predicting Characteristics and Recurrence of Atrial Fibrillation. Frontiers in Cardiovascular Medicine. 2022;9:813085. DOI: 10.3389/fcvm.2022.813085
22. Matos D, Ferreira AM, Freitas P, Rodrigues G, Carmo J, Costa F et al. The Relationship between Epicardial Fat and Atrial Fibrillation Cannot Be Fully Explained by Left Atrial Fibrosis. Arquivos Brasileiros de Cardiologia. 2021;118(4):737–42. DOI: 10.36660/abc.20201083
23. Ilyushenkova J, Sazonova S, Popov E, Zavadovsky K, Batalov R, Archakov E et al. Radiomic phenotype of epicardial adipose tissue in the prognosis of atrial fibrillation recurrence after catheter ablation in patients with isolated atrial fibrillation. Research Square. 2022. [Av. at: https://www.researchsquare.com/article/rs-1456502/v1. DOI: 10.21203/rs.3.rs-1456502/v1]
24. Jian B, Li Z, Wang J, Zhang C. Correlation analysis between heart rate variability, epicardial fat thickness, visfatin and AF recurrence post radiofrequency ablation. BMC Cardiovascular Disorders. 2022;22(1):65. DOI: 10.1186/s12872-022-02496-x
25. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European Journal of Epidemiology. 2010;25(9):603–5. DOI: 10.1007/s10654-010-9491-z
26. Lavie CJ, Pandey A, Lau DH, Alpert MA, Sanders P. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. Journal of the American College of Cardiology. 2017;70(16):2022–35. DOI: 10.1016/j.jacc.2017.09.002
27. Lau DH, Schotten U, Mahajan R, Antic NA, Hatem SN, Pathak RK et al. Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. European Heart Journal. 2016;37(20):1573–81. DOI: 10.1093/eurheartj/ehv375
28. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. European Heart Journal. 2016;38(17):1294–302. DOI: 10.1093/eurheartj/ehw045
29. Gaeta M, Bandera F, Tassinari F, Capasso L, Cargnelutti M, Pelissero G et al. Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis. EP Europace. 2017;19(5):747–52. DOI: 10.1093/europace/euw398
30. Sepehri Shamloo A, Dagres N, Dinov B, Sommer P, Husser-Bollmann D, Bollmann A et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and metaanalysis. IJC Heart & Vasculature. 2019;22:132–8. DOI: 10.1016/j.ijcha.2019.01.003
Review
For citations:
Golukhova E.Z., Bulaeva N.I., Alexandrova S.A., Saparbaev A.A., Abgaryan A.A., Berdibekov B.Sh. Quantification of epicardial adipose tissue by computed tomographic scanning as a prognostic criterion of atrial fibrillation recurrence after catheter ablation. Kardiologiia. 2023;63(8):3-10. https://doi.org/10.18087/cardio.2023.8.n2168